Table 2.
HSV serology | HSV FASCIA | EBV serology | EBV FASCIA | CMV serology | CMV FASCIA | VZV serology | VZV FASCIA | |
---|---|---|---|---|---|---|---|---|
1 | − | N | − | N | + | N | + | N |
2 | + | N | + | N | + | P | + | N |
3 | + | N | + | P | − | N | + | N |
4 | + | P | + | P | + | N | + | P |
5 | − | N | + | N | − | N | + | N |
6 | + | N | + | P | − | N | + | N |
7 | + | P | + | P | − | N | + | P |
8 | − | N | + | P | − | N | + | N |
9 | − | N | + | N | − | N | + | N |
10 | − | N | − | N | + | P | + | N |
11 | + | N | + | P | + | N | + | N |
12 | − | N | + | P | − | N | + | N |
13 | − | N | + | P | + | N | + | N |
14 | − | N | − | P | + | N | + | P |
15 | + | P | + | P | − | N | + | P |
16 | − | N | + | P | − | N | + | N |
17 | + | P | + | P | + | P | + | N |
18 | − | N | − | P | + | N | + | N |
19 | + | P | + | P | + | P | + | P |
20 | − | N | + | P | + | P | + | P |
21 | − | N | + | P | − | N | + | P |
22 | − | N | − | P | − | N | + | P |
% Positive | 41 | 55a | 77 | 82a | 50 | 45a | 100 | 36a |
−, negative donor serology, +, positive donor serology, N, negative FASCIA response, P, positive FASCIA response.
Frequency‐positive serology corresponding with positive FASCIA response.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.